<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36992491</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15030783</ELocationID><Abstract><AbstractText>There have been suggestions that Long COVID might be purely functional (meaning psychological) in origin. Labelling patients with neurological dysfunction in Long COVID as having functional neurological disorder (FND) in the absence of proper testing may be symptomatic of that line of thought. This practice is problematic for Long COVID patients, as motor and balance symptoms have been reported to occur in Long COVID frequently. FND is characterized by the presentation of symptoms that seem neurological but lack compatibility of the symptom with a neurological substrate. Although diagnostic classification according to the ICD-11 and DSM-5-TR is dependent predominantly on the exclusion of any other medical condition that could account for the symptoms, current neurological practice of FND classification allows for such comorbidity. As a consequence, Long COVID patients with motor and balance symptoms mislabeled as FND have no longer access to Long COVID care, whereas treatment for FND is seldom provided and is ineffective. Research into underlying mechanisms and diagnostic methods should explore how to determine whether motor and balance symptoms currently diagnosed as FND should be considered one part of Long COVID symptoms, in other words, one component of symptomatology, and in which cases they correctly represent FND. Research into rehabilitation models, treatment and integrated care are needed, which should take into account biological underpinnings as well as possible psychological mechanisms and the patient perspective.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van der Feltz-Cornelis</LastName><ForeName>Christina M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-6925-8956</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, Hull York Medical School, (HYMS), University of York, York YO10 5DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moriarty</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-0770-3262</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, Hull York Medical School, (HYMS), University of York, York YO10 5DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strain</LastName><ForeName>William David</ForeName><Initials>WD</Initials><Identifier Source="ORCID">0000-0002-6826-418X</Identifier><AffiliationInfo><Affiliation>Diabetes and Vascular Medicine Research Centre, Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter EX2 5AX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204829</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>COV-LT2-0043</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003291" MajorTopicYN="Y">Conversion Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">balance symptoms</Keyword><Keyword MajorTopicYN="N">classification</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">functional</Keyword><Keyword MajorTopicYN="N">functional neurological disorder (FND)</Keyword><Keyword MajorTopicYN="N">motor symptoms</Keyword><Keyword MajorTopicYN="N">neurological dysfunction</Keyword></KeywordList><CoiStatement>C.M.V.d.F.-C. received travel and accommodation in the UK for a lecture from The Lloyd Register Foundation and travel and accommodation in the UK and an honorarium payment from Janssen UK related to a lecture at the Big Questions in Neuroscience Annual meeting. She received funding from NIHR for three projects, of which STIMULATE-ICP is one; from the British Medical Association, the EU Horizon Programme, and from the Netherlands Organization for Health Research and Development. W.D.S. has received research grants from AstraZeneca, Bayer, Novo Nordisk and Takeda, and speaker and/or advisory board honoraria from AstraZeneca, Bayer, Merck, NovoNordisk, Pfizer, Sanofi Aventis and Takeda. W.D.S. is supported by the NIHR Exeter Clinical Research Facility. A.S.M. has no COI to report. The views expressed in this publication are those of the authors and not necessarily those of the NIHR Exeter Clinical Research Facility, the NHS, the NIHR or the Department of Health in England. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36992491</ArticleId><ArticleId IdType="pmc">PMC10059786</ArticleId><ArticleId IdType="doi">10.3390/v15030783</ArticleId><ArticleId IdType="pii">v15030783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NICE  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 2022.  [(accessed on 1 March 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation></Reference><Reference><Citation>Ayoubkhani D., Pawelek P. Infection Survey Data, Office for National Statistics.  [(accessed on 3 November 2022)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022.</Citation></Reference><Reference><Citation>Spiers N. Recognising and bearing the burden of long COVID-related disability. Br. J. Gen. Pract. 2022;72:70. doi: 10.3399/bjgp22X718361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp22X718361</ArticleId><ArticleId IdType="pmc">PMC8813105</ArticleId><ArticleId IdType="pubmed">35091402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain F.A. Facilitating care: A biopsychosocial perspective on long COVID. Br. J. Gen. Pr. 2022;72:30&#x2013;31. doi: 10.3399/bjgp22X718181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp22X718181</ArticleId><ArticleId IdType="pmc">PMC8714505</ArticleId><ArticleId IdType="pubmed">34972801</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Office for National Statistics  Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK: 2 February 2023.  [(accessed on 19 February 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023.</Citation></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. MMWR. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. Eclinicalmedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  A Clinical Case Definition of Post COVID-19 Condition by a DELPHI Consensus, 6 October 2021.  [(accessed on 14 February 2022)];2021  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Takao M., Ohira M. Neurological post-acute sequelae of SARS-CoV-2 infection. Psychiatry Clin. Neurosci. 2023;77:72&#x2013;83. doi: 10.1111/pcn.13481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13481</ArticleId><ArticleId IdType="pmc">PMC9538807</ArticleId><ArticleId IdType="pubmed">36148558</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M., Zaker Harofteh B., Etemadifar M., Sedaghat N., Nouri H. Movement Disorders Associated with COVID-19. Park. Dis. 2021;2021:3227753. doi: 10.1155/2021/3227753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/3227753</ArticleId><ArticleId IdType="pmc">PMC8592762</ArticleId><ArticleId IdType="pubmed">34790346</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID) Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz O., Mutlu B.&#xd6;., Yaman D., Bayazit D., Demirhan H., Bayazit Y.A. Assessment of balance after recovery from COVID-19 disease. Auris Nasus Larynx. 2022;49:291&#x2013;298. doi: 10.1016/j.anl.2021.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anl.2021.08.011</ArticleId><ArticleId IdType="pmc">PMC8405449</ArticleId><ArticleId IdType="pubmed">34503884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden. Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>@LongTiredRoad Twitteraccount posted July 11 2022.  [(accessed on 1 March 2023)].  Available online:  https://twitter.com/LongTiredRoad/status/1546625708314820608?t=nrG4MFbLIkU9agsQ5Qtiiw&amp;s=03.</Citation></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; Arlington, VA, USA: 2022. Text revision (DSM-5-TR)</Citation></Reference><Reference><Citation>World Health Organisation (WHO) The International Statistical Classification of Diseases and Related Health Problems (11th Rev. ICD-11) World Health Organisation (WHO); Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>Varley D., Sweetman J., Brabyn S., Lagos D., Van der Feltz-Cornelis C. The clinical management of functional neurological disorder: A scoping review of the literature. J. Psychosom. Res. 2022;165:111121. doi: 10.1016/j.jpsychores.2022.111121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.111121</ArticleId><ArticleId IdType="pubmed">36549074</ArticleId></ArticleIdList></Reference><Reference><Citation>Forshaw D., Wall E.C., Prescott G., Dehbi D.M., Green A., Attree E., Hismeh L., Strain W.D., Crooks M.G., Watkins C., et al. STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol. medRxiv. 2022 doi: 10.1371/journal.pone.0272472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272472</ArticleId><ArticleId IdType="pmc">PMC9931100</ArticleId><ArticleId IdType="pubmed">36791116</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Feltz-Cornelis C.M., Sweetman J., Allsopp G., Attree E., Crooks M.G., Cuthbertson D.J., Forshaw D., Gabbay M., Green A., Heightman M., et al. STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol. PLoS ONE. 2022;17:e0277936. doi: 10.1371/journal.pone.0277936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277936</ArticleId><ArticleId IdType="pmc">PMC9710789</ArticleId><ArticleId IdType="pubmed">36449461</ArticleId></ArticleIdList></Reference><Reference><Citation>STIMULATE-ICP  Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways.  [(accessed on 17 January 2023)].  Available online:  https://www.stimulate-icp.org/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9710789</ArticleId><ArticleId IdType="pubmed">36449461</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Feltz-Cornelis C.M., Brabyn S., Allen S.F., Reilly J., Clarke C., de Vroege L., Gilbody S., Whittington M., Lagos D. Conversion and Neuro-inflammation Disorder Observational Study (CANDO). Protocol of a feasibility study. Eur. J. Psychiatry. 2020;34:164&#x2013;172. doi: 10.1016/j.ejpsy.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpsy.2020.04.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Feltz-Cornelis C., Brabyn S., Ratcliff J., Varley D., Allgar V., Gilbody S., Clarke C., Lagos D. Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study. Brain Behav. Immun. Health. 2021;13:100228. doi: 10.1016/j.bbih.2021.100228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100228</ArticleId><ArticleId IdType="pmc">PMC8474571</ArticleId><ArticleId IdType="pubmed">34589743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover C.F. A new sign for the detection of malingering and functional paresis of the lower extremities. JAMA. 1908;51:746&#x2013;747. doi: 10.1001/jama.1908.25410090028001h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1908.25410090028001h</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehndiratta M.M., Kumar M., Nayak R., Garg H., Pandey S. Hoover&#x2019;s sign: Clinical relevance in Neurology. J. Postgrad. Med. 2014;60:297&#x2013;299. doi: 10.4103/0022-3859.138769.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.138769</ArticleId><ArticleId IdType="pubmed">25121372</ArticleId></ArticleIdList></Reference><Reference><Citation>Daum C., Hubschmid M., Aybek S. The value of &#x2018;positive&#x2019; clinical signs for weakness, sensory and gait disorders in conversion disorder: A systematic and narrative review. J. Neurol. Neurosurg. Psychiatry. 2014;85:180&#x2013;190. doi: 10.1136/jnnp-2012-304607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304607</ArticleId><ArticleId IdType="pubmed">23467417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., &#x15a;wi&#x105;tkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Gonzalez A.B., Master H., Gall N., Halpin S., Rogers N., Greenhalgh T. Orthostatic tachycardia after COVID-19. BMJ. 2023;380:e073488. doi: 10.1136/bmj-2022-073488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073488</ArticleId><ArticleId IdType="pubmed">36828559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., S&#xe1;nchez-Serrano N., Mielgo-Ayuso J., Garc&#xed;a-Hern&#xe1;ndez J.L., Gonz&#xe1;lez-Bernal J.J., Seco-Calvo J. Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? J. Clin. Med. 2021;10:5799. doi: 10.3390/jcm10245799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="pubmed">34945095</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023:1&#x2013;2. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R., Baker J.R., Siddiqui T., Ranada S.I., Soroush A., Karalasingham K., Ahmad H., Mavai V., Ayala Valani L.M., Ambreen S., et al. Objective hemodynamic cardiovascular autonomic abnormalities in postacute sequelae of COVID-19. Can. J. Cardiol. 2022. Advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9733966</ArticleId><ArticleId IdType="pubmed">36509178</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Feltz-Cornelis C.M., Allen S.F., van Eck van der Sluijs J.F. Misdiagnosis of an underlying medical condition as Conversion Disorder/Functional Neurological Disorder (CD/FND) still occurs. Gen. Hosp. Psychiatry. 2020;65:43&#x2013;46. doi: 10.1016/j.genhosppsych.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2020.05.003</ArticleId><ArticleId IdType="pubmed">32464427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R., Biswas U., Roy D., Pandit A., Lahiri D., Kanti Ray B., Benito-Leon J. De Novo Movement Disorders and COVID-19. Mov. Disord. Clin. Pract. 2021;8:669&#x2013;680. doi: 10.1002/mdc3.13224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13224</ArticleId><ArticleId IdType="pmc">PMC8250792</ArticleId><ArticleId IdType="pubmed">34230886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J.J., Movassaghi M., Gordy D., Olson M.G., Zhang T., Khurana M.S., Chen Z., Perez-Rosendahl M., Thammachantha S., Singer E.J., et al. Neuropathology of COVID-19 (neuro-COVID) Free Neuropathol. 2021;18:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Kwe Yinda C., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C.Y., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., Systrom D., Marciano S.P., Felsenstein D., Mullally W.J., Pilgrim D.M. Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19. Ann. Neurol. 2022;91:367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., Van Elzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Lau E.H.Y., Wu P., He X., Lau E.H., Wu P., Deng X., Wang J., Hao X., Lau Y.C., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020;26:672&#x2013;675. doi: 10.1038/s41591-020-0869-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0869-5</ArticleId><ArticleId IdType="pubmed">32296168</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra A., Clark JRKang A.K., Batra A., Clark J.R., Kang A.K., Ali S., Patel T.R., Shlobin N.A., Hoffman S.C., Lim P.H., et al. Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. GeroScience. 2022;44:1241&#x2013;1254. doi: 10.1007/s11357-022-00561-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00561-z</ArticleId><ArticleId IdType="pmc">PMC9090540</ArticleId><ArticleId IdType="pubmed">35538386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Li C., Zhou Y., Wang B., Zhang J. Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2.  [(accessed on 1 March 2023)];Quant. Imaging Med. Surg. 2020 10:5. doi: 10.21037/qims.2020.04.08. Available online:  https://qims.amegroups.com/article/view/41170.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims.2020.04.08</ArticleId><ArticleId IdType="pmc">PMC7242292</ArticleId><ArticleId IdType="pubmed">32489935</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., Aldamiz T., Diez C., Perez L., Fanciulli C., et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A., Neves P.F., Lima S.S., Lopes J.D.C., Torres M.K.D.S., Vallinoto I.M., Bichara C.D., Dos Santos E.F., de Brito M.T., da Silva A.L.S., et al. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe8;gue I., Adams C., Stone J., Perez D.L. Structural alterations in functional neurological disorder and related conditions: A software and hardware problem? NeuroImage Clin. 2019;22:101798. doi: 10.1016/j.nicl.2019.101798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101798</ArticleId><ArticleId IdType="pmc">PMC6484222</ArticleId><ArticleId IdType="pubmed">31146322</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders C., Sperling S., Bendstrup E. A new paradigm is needed to explain long COVID.  [(accessed on 1 March 2023)];Lancet Respir. Med. 2023 11:e12&#x2013;e13. doi: 10.1016/S2213-2600(22)00501-X. Available online:  2213-2600(22)00501-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00501-X</ArticleId><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Quan L., Chavarro J.E., Slopen N., Kubzansky L.D., Koenen K.C., Kang J.H., Weisskopf M.G., Branch-Elliman W., Roberts A.L. Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post&#x2013;COVID-19 Conditions. JAMA Psychiatry. 2022;79:1081&#x2013;1091. doi: 10.1001/jamapsychiatry.2022.2640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludman E.J., Katon W., Russo J., Von Korff M., Simon G., Ciechanowski P., Lin E., Bush T., Walker E., Young B. Depression and diabetes symptom burden. Gen. Hosp. Psychiatry. 2004;26:430&#x2013;436. doi: 10.1016/j.genhosppsych.2004.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2004.08.010</ArticleId><ArticleId IdType="pubmed">15567208</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N., Heightman M., Hillman T., Wall E., Bell R., Kessler A., Neave L., Doyle A., Devaraj A., Singh D., et al. Impaired exercise capacity in post-COVID-19 syndrome: The role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041&#x2013;4048. doi: 10.1182/bloodadvances.2021006944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021006944</ArticleId><ArticleId IdType="pmc">PMC9098525</ArticleId><ArticleId IdType="pubmed">35543533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J., Astill S.L., Sivan M. The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study. Int. J. Environ. Res. Public Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health and Human Services  Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.  [(accessed on 1 March 2023)]; Available online:  https://www.cdc.gov/nchs/products/index.htm.</Citation></Reference><Reference><Citation>Zhang L., Beghi E., Tomson T., Beghi M., Erba G., Chang Z. Mortality in patients with psychogenic non-epileptic seizures a population-based cohort study. J. Neurol. Neurosurg. Psychiatry. 2022;93:379&#x2013;385. doi: 10.1136/jnnp-2021-328035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-328035</ArticleId><ArticleId IdType="pubmed">35086937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nightscales R., McCartney L., Auvrez C., Tao G., Barnard S., Malpas C.B., Perucca P., McIntosh A., Chen Z., Sivathamboo S., et al. Mortality in patients with psychogenic nonepileptic seizures. Neurology. 2020;95:e643&#x2013;e652. doi: 10.1212/WNL.0000000000009855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009855</ArticleId><ArticleId IdType="pubmed">32690794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad F.B., Anderson R.N., Cisewski J.A., Sutton P.D. Identification of Deaths With Post-Acute Sequelae of COVID-19 from Death Certificate Literal Text: United States, January 1, 2020&#x2013;June 30, 2022. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2022. Vital statistics Survey Report.</Citation></Reference><Reference><Citation>Moretzky B.A. Mortality in Patients with Psychogenic Non-Epileptic Seizures. Comment. Practice Update Neurology 26 August 2020.  [(accessed on 17 January 2023)].  Available online:  https://www.practiceupdate.com/content/mortality-in-patients-with-psychogenic-nonepileptic-seizures/105154.</Citation></Reference><Reference><Citation>NHS England . National Guidance for Post-COVID Syndrome Assessment Clinics: NHS England and NHS Improvement. NHS England; Leeds, UK: 2021.</Citation></Reference><Reference><Citation>New Clinical Trial Aims to Improve Diagnosis, Treatment and Rehabilitation of Long COVID. Jul 19, 2021.  [(accessed on 1 March 2023)].  Available online:  https://www.arc-nt.nihr.ac.uk/news-and-events/2021/july/new-clinical-trial-aims-to-improve-diagnosis-treatment-and-rehabilitation-of-long-covid/</Citation></Reference><Reference><Citation>Teodoro T., Chen J., Gelauff J., Edwards M.J. Functional Neurological Disorder in people with Long-Covid: A Systematic Review. Eur. J. Neurol. 2023 doi: 10.1111/ene.15721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15721</ArticleId><ArticleId IdType="pubmed">36719069</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Feltz-Cornelis C.M., Heightman M., Allssop G. Learning from Long COVID. Integrated care for Multiple Long Term Conditions. Br. J. Gen. Pract. Submitted .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10147422</ArticleId><ArticleId IdType="pubmed">37105737</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>